A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

NCT00685113 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1104

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: DR-3001
DRUG: DR-3001
DRUG: Placebo

Sponsor

Duramed Research